Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
MedPlus Health Services Ltd. ( (IN:MEDPLUS) ) just unveiled an announcement.
MedPlus Health Services Ltd. has disclosed that its subsidiary Optival Health Solutions Private Limited has received six suspension orders affecting the drug licences of pharmacy stores in Karnataka and Telangana. Authorities in Bangalore, Nalgonda and Patancheruvu ordered temporary suspensions ranging from one to four days at specific outlets, citing violations under Rule 65 of the Drugs and Cosmetics Act, 1940 and corresponding rules, leading to an estimated aggregate potential revenue loss of a few lakh rupees; while the financial impact is limited, the regulatory action underscores ongoing compliance scrutiny in the pharmaceutical retail sector and could prompt tighter operational controls at impacted locations.
More about MedPlus Health Services Ltd.
MedPlus Health Services Limited is an Indian healthcare retailer operating a large chain of pharmacy stores through subsidiaries such as Optival Health Solutions Private Limited. The company focuses on providing pharmaceutical products and related health services across multiple states, including Karnataka and Telangana, targeting urban and semi-urban markets through its extensive store network.
Average Trading Volume: 21,219
Technical Sentiment Signal: Strong Buy
Current Market Cap: 98.09B INR
For an in-depth examination of MEDPLUS stock, go to TipRanks’ Overview page.